Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

953 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The 18F phantom clinical trials qualification for 18F-FDG-PET scanning adopted by GELTAMO (Grupo Español de Linfomas/Trasplante Autólogo de Médula Ósea).
Bergesio F, De Maggi A, Coronado M, Pardal E, Plaza R, Hernández AC, Sarandeses MDP, Cortes M, Setoain X, Simó M, Rotger A, Grande C, Caballero MD, Chauvie S. Bergesio F, et al. Among authors: cortes m. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2021 May-Jun;40(3):149-154. doi: 10.1016/j.remn.2020.06.003. Epub 2021 Jan 21. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2021. PMID: 33485832 English, Spanish.
[Solitary plasmocytoma of the pelvis. Utility of bone scintigraphy].
Benítez Segura A, Cortés M, García FJ, Mora J, Castell M, González MJ, Martín-Comín J. Benítez Segura A, et al. Among authors: cortes m. Rev Esp Med Nucl. 2001 Feb;20(1):42-3. Rev Esp Med Nucl. 2001. PMID: 11181331 Spanish. No abstract available.
[Isotopic renal study in diabetic nephropathy].
Benítez Segura A, Martín-Comín J, Ricart Y, González MT, Cortés M, Roca M, Díaz MC, Ramos M. Benítez Segura A, et al. Among authors: cortes m. Rev Esp Med Nucl. 2002 Feb;21(1):12-6. Rev Esp Med Nucl. 2002. PMID: 11820996 Spanish.
18F-FDG PET/CT for early prediction of response to neoadjuvant lapatinib, trastuzumab, and their combination in HER2-positive breast cancer: results from Neo-ALTTO.
Gebhart G, Gámez C, Holmes E, Robles J, Garcia C, Cortés M, de Azambuja E, Fauria K, Van Dooren V, Aktan G, Coccia-Portugal MA, Kim SB, Vuylsteke P, Cure H, Eidtmann H, Baselga J, Piccart M, Flamen P, Di Cosimo S. Gebhart G, et al. Among authors: cortes m. J Nucl Med. 2013 Nov;54(11):1862-8. doi: 10.2967/jnumed.112.119271. Epub 2013 Oct 3. J Nucl Med. 2013. PMID: 24092940 Free article. Clinical Trial.
953 results